Atlas FDA

FINEVISION HP Trifocal IOLs

FDA premarket approval P240038 · decided 2025-09-10

Approval details

PMA number
P240038
Trade name
FINEVISION HP Trifocal IOLs
Generic name
intraocular lens
Applicant
Beaver Visitec International, Inc.
Date received
2024-10-30
Decision date
2025-09-10
Days to decision
315 days
Decision code
APPR
Product code
HQL
Advisory committee
Ophthalmic
Expedited review
No
Location
Waltham, MA
Statement
Approval for the FINEVISION HP Trifocal Intraocular Lens (IOL). The FlNEVISION HP Trifocal intraocular Lens is indicated for primary implantation in the capsular bag in the posterior chamber of the eye for the visual correction of aphakia in adult patients, with less than 1 diopter of pre-existing corneal astigmatism, in whom a cataractous lens has been removed by phacoemulsification. The lens mitigates the effects of presbyopia by providing improved intermediate and near visual acuity, while ma

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Leos Laser and Endoscopy System (K240615)Beaver-Visitec International, Inc.2025-04-03